AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 98 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,000 | -18.2% | 13,305 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | -47.6% | 13,305 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -52.3% | 13,305 | 0.0% | 0.00% | – |
| Q3 2018 | $44,000 | +46.7% | 13,305 | 0.0% | 0.00% | – |
| Q2 2018 | $30,000 | -23.1% | 13,305 | 0.0% | 0.00% | – |
| Q1 2018 | $39,000 | -79.6% | 13,305 | -91.6% | 0.00% | -100.0% |
| Q3 2015 | $191,000 | -41.0% | 157,930 | -15.1% | 0.00% | 0.0% |
| Q2 2015 | $324,000 | +20.0% | 186,030 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $270,000 | +81.2% | 186,030 | +4.6% | 0.00% | 0.0% |
| Q4 2014 | $149,000 | -24.4% | 177,830 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $197,000 | -39.4% | 177,830 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $325,000 | +22.2% | 177,830 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $266,000 | – | 177,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
| New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
| RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
| NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
| Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
| 683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
| Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
| EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
| Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |